Recurrence factors and prevention of complications of pediatric differentiated thyroid cancer

Asian Journal of Surgery
|October 5, 2016
PubMed

Insights

Pediatric differentiated thyroid cancer has a high lymph node metastasis rate, but prognosis is good. Lesion number, extrathyroidal extension, and lymph node metastasis are recurrence risk factors, while total resection may increase complications.

Area of Science:

  • Pediatric Oncology
  • Surgical Oncology
  • Endocrinology

Background:

  • Differentiated thyroid cancer (DTC) in children presents unique challenges regarding recurrence and treatment complications.
  • Understanding factors influencing DTC recurrence is crucial for optimizing pediatric patient outcomes.

Purpose of the Study:

  • To identify clinical and pathological factors associated with differentiated thyroid cancer recurrence in pediatric patients.
  • To guide surgical treatment strategies for improved efficacy and reduced complications in pediatric DTC.

Main Methods:

  • Prospective analysis of 43 pediatric DTC cases (papillary and follicular) from March 2008 to June 2014.
  • Surgical interventions included subtotal or total resection based on lesion and lymph node status.
  • Statistical analysis (Kaplan-Meier, Cox regression, logistic regression) investigated recurrence and complication risk factors.

Main Results:

  • High lymph node metastasis rate (67.44%), with common involvement of Area VI nodes.
  • Postoperative complications (hypocalcemia, hoarseness) occurred in 13.95% of cases.
  • Recurrence rate was 11.63%, with lesion number, extrathyroidal extension, and lymph node metastasis identified as significant risk factors (p<0.05).
  • Total resection did not reduce recurrence but was associated with increased hypocalcemia and hoarseness (OR=2.537, p=0.037).

Conclusions:

  • Pediatric DTC exhibits a high metastatic potential but generally good prognosis.
  • Surgical approach should carefully consider lesion characteristics to minimize recurrence and complications.
  • Adherence to surgical indicators and thorough understanding of local disease are vital for optimal pediatric DTC management.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
349
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
309
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
414
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
93
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
626
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
6.4K